03 Aug Fangyun Wu
Posted at 16:12h
in
Bio
Fangyun Wu holds a Master’s degree in Accounting from China and a Master’s degree in Statistics from the University of Western Ontario. She joined the Institute for Clinical Evaluative Sciences (ICES) as a senior research analyst in 2009 and since then has participated in studies looking at various areas including primary care, cardiovascular disease, cancer, with primary focus on chronic disease and drug effect and safety. She joined the CNODES team – Ontario site as an analyst in 2011 and has been involved in many CNODES projects.
CNODES Projects
Incretin based drugs and the risk of pancreatic cancer: international multicentre cohort study
Analyst, OntarioVentricular tachyarrhythmia and sudden cardiac death with domperidone use in Parkinson’s Disease
Analyst, OntarioA multicenter observational study of incretin-based drugs and heart failure
Analyst, OntarioSerotonin-norepinephrine reuptake inhibitors and the risk of AKI: A cohort study of eight administrative databases and meta-analysis
Analyst, OntarioHigher potency statins and the risk of new diabetes: multicentre, observational study of administrative databases
Analyst, OntarioProton pump inhibitors and the risk of hospitalisation for community-acquired pneumonia: replicated cohort studies with meta-analysis
Analyst, OntarioUse of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases
Analyst, OntarioAssociation between incretin-based drugs and the risk of acute pancreatitis
Analyst, Ontario- Analyst, Ontario
Occurrence of pregnancy and pregnancy outcomes during isotretinoin therapy
Analyst, OntarioAtypical antipsychotics and hyperglycemic emergencies: multicentre, retrospective cohort study of administrative data
Analyst, Ontario- Analyst, Ontario
Impact of using concomitant conventional DMARDs on adherence to biologic DMARD treatment in rheumatoid arthritis: Multi-centre, population-based cohort study
Analyst, OntarioComparative safety of direct oral anticoagulants and warfarin in patients with venous thromboembolism: a multicenter observational study of administrative databases
Analyst, OntarioComparison of pregnancy outcomes of patients treated with ondansetron vs alternative antiemetic medications in a multinational, population-based cohort
Lead AnalystComparison of pregnancy outcomes of patients treated with ondansetron vs alternative antiemetic medications in a multinational, population-based cohort
Analyst, OntarioUtilization and adverse outcomes of fluconazole during pregnancy
Lead AnalystUtilization and adverse outcomes of fluconazole during pregnancy
Analyst, OntarioCNODES simulated data platform
CollaboratorSafety of bowel cleansers when combined with bisacodyl stimulant laxative
Analyst, OntarioSodium glucose cotransporter 2 inhibitors and risk of major adverse cardiovascular events: multi-database retrospective cohort study
Analyst, OntarioPrescription ranitidine use and population exposure in 6 Canadian provinces, 1996 to 2019: a serial cross-sectional analysis
Analyst, OntarioSodium-glucose co-transporter-2 inhibitors and the risk of urosepsis: A multi-site, prevalent new-user cohort study
Analyst, OntarioOff-label postpartum use of domperidone in Canada: a multidatabase cohort study
Analyst, OntarioSodium-glucose cotransporter 2 inhibitors and the risk of below-knee amputation: a multicenter observational study
Analyst, OntarioSodium-glucose cotransporter-2 inhibitors and the risk for diabetic ketoacidosis: a multicenter cohort study
Analyst, OntarioIdentification of incident pancreatic cancer in Ontario administrative health data: A validation study
Collaborator, OntarioUse of systemic oral fluoroquinolones in Canada
Analyst, OntarioFluoroquinolone use for uncomplicated urinary tract infections in women: a retrospective cohort study
Analyst, OntarioFluoroquinolone use for acute bacterial sinusitis
Analyst, OntarioComparative effectiveness of fluoroquinolone antibiotic use in uncomplicated acute exacerbations of chronic obstructive pulmonary disease: a multi-cohort study
Analyst, OntarioCharacteristics of new users of newer antidiabetic drugs in Canada and the United Kingdom
Analyst, OntarioValsartan, Losartan and Irbesartan use in the USA, UK, Canada and Denmark after the nitrosamine recalls: a descriptive cohort study
Analyst, Ontario- Analyst, Ontario
Patterns of steroid utilization in COVID-19 patients
Analyst, OntarioRisk of Arterial and Venous Thrombotic Events Among Patients with COVID-19: A Multi-National Collaboration of Regulatory Agencies from Canada, Europe, and United States
Analyst, OntarioValidity of diagnoses of SARS-CoV-2 infection in Canadian administrative health data: a multiprovince, population-based cohort study
Analyst, OntarioAtypical antipsychotics and cardiomyopathy: a population-based cohort study
Analyst, OntarioOutpatient Nirmatrelvir-Ritonavir and Remdesivir Utilization in Canada
Analyst, OntarioUtilization Analysis of Tofacitinib and Other Drugs Among Individuals with Ulcerative Colitis: Feasibility Analysis
Analyst, OntarioSafety of Monitoring During Use of Ozempic in People with Diabetes: A CDM Pilot Project
Analyst, OntarioAssociation Between Opioid Use and the Development of Diverticulitis
Analyst, OntarioLong-Acting Inhalable Drugs for Chronic Obstructive Pulmonary Disease
Analyst, OntarioUtilization of Antidiabetic Drugs During Pregnancy: A CDM Pilot Project
Analyst, OntarioIntentional Self-Harm with GLP-1 Receptor Agonists for Diabetes
Analyst, Ontario